Overview
What is Project Als Inc?
Project Als Inc, located at 2585 BROADWAY STE 202, New York, NY 10032, is a dedicated nonprofit organization focusing on scientific medical research. Their primary mission is to find effective treatments and, ultimately, a cure for Amyotrophic Lateral Sclerosis (ALS), a motor neuron disease that is often fatal. They achieve this goal by fostering collaboration and information sharing among researchers working on related diseases like Parkinson's and Multiple Sclerosis. A significant aspect of their work involves the development of Prosetin, which is being prepared for submission to the FDA for clinical drug trial approval. Project Als Inc employs a team of 8 individuals, all of whom are committed to advancing our understanding and treatment of ALS, also known as Lou Gehrig's Disease.
Official website here: www.projectals.org
Is Project Als Inc legitimate?
Project Als Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Project Als Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $450,932
Professional Fundraising Fees: $0
Other Salaries and Wages: $246,894
For more financial information, click here
Official website here: www.projectals.org
What is the mission statement of Project Als Inc?
Project Als Inc's mission is centered around combating Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. Their primary objective is to recruit renowned researchers and clinicians worldwide, encouraging collaboration to gain a profound understanding of ALS and develop the first effective treatments for this debilitating motor neuron disease. The organization funds scientific medical research, promoting information sharing among researchers for related diseases such as Parkinson's and Multiple Sclerosis. They are also working on Prosetin for potential approval by the FDA for clinical drug trials.
Official website here: www.projectals.org
Who is the CEO of Project Als Inc?
What is the revenue of Project Als Inc?
Who are the executives of Project Als Inc and what are their salaries?
The average compensation at Project Als Inc during 2022 was $87,228. There are 8 employees and 10 volunteers at Project Als Inc.
Here are 31 key members and their salaries:
- Valerie Estess (Vice President) [Trustee/Director]
- Meredith Estess Hulbert (President) [Trustee/Director]
- Erin Flemming (Director Of Research - Cor)
- Robert S Kaplan (Chair) [Trustee/Director]
- Debbie Wilpon (Chair) [Trustee/Director]
- Rob Burnett (Director)
- Michael Berman (Director)
- Darci Carlton (Director)
- Chad Cascarilla (Director)
- Gena Fajgenbaum Combs (Director Through 2021)
- F Jonathan Dracos (Director)
- Marcie Fleck (Director)
- Arthur Frasier (Director)
- Stacey Griffith (Director)
- Simon Halls (Director)
- Peter J Hulbert (Director)
- David L Jaffe (Director)
- Nancy Jarecki (Director)
- Daniel Kellison (Director)
- Staci Kirchhoff (Director)
- Sue Leibman (Director)
- Martha Mccully (Director)
- Jack Merrill (Director)
- Rob Morrow (Director)
- Regina Kulik Scully (Director)
- Lori Hirshliefer Sills (Director)
- Lawrence Tarica (Director)
- Christine Taylor (Director)
- Debra Wasserman (Director)
- Bonnie Verbitsky (Director)
- Bruce Spohler (Director From 11/2021)
Official website here: www.projectals.org
Where can I find the form 990 for Project Als Inc?
The Project Als Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.projectals.org
Learn more at the official website: www.projectals.org
Mission Statement of Project Als Inc
Project Als Inc, a renowned organization, is dedicated to advancing our understanding and seeking effective treatments for Amyotrophic Lateral Sclerosis (ALS), often referred to as Lou Gehrig's disease. Their mission is to assemble the world's leading research scientists and clinicians, encouraging collaboration and information sharing among them. This collective effort aims to unravel the mysteries of ALS, a fatal motor neuron disease, and other related conditions such as Parkinson's and Multiple Sclerosis.
In pursuit of this goal, Project Als Inc provides funding for medical research. By promoting collaboration and information exchange among researchers, the organization strives to accelerate the discovery of treatments and, ultimately, a cure for ALS. One of their significant projects involves the development of Prosetin, which is currently undergoing the necessary procedures for submission to the Food and Drug Administration (FDA) for approval of clinical drug trials. This initiative highlights Project Als Inc's commitment to tackling ALS head-on, leveraging scientific research to bring hope and potential solutions to those affected by this debilitating disease.
Impact
This information is meant to be a general summary of Project Als Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Project ALS Inc's impact is focused on working towards an understanding and treatments for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease. Through grants and research funding, they support scientific medical research aimed at finding treatments and ultimately a cure for this fatal motor neuron disease. Additionally, they promote collaboration and information sharing among researchers for all related diseases such as Parkinson's and Multiple Sclerosis. Their efforts include prosetin development for FDA submission for clinical drug trial approval. The organization's mission is to recruit the world's best research scientists and clinicians to work together towards an understanding of and the first effective treatments for ALS.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
1998
Phone
(212) 420-7382
Principal Officer
Meredith Estess
Main Address
2585 BROADWAY STE 202, NEW YORK, NY, 10032
Website
www.projectals.org
NTEE Category
Code: G50 - Disease
If you are a representative of Project Als Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.